Rodolfo Fernando Rivera, What is new in the assessment of etiopathogenetic modalities of cardiorenal diseases? | 10.46793/KARNEF25.009R | 9-12 |
Vladimir Petrović, Renal dysfunction in cardiovascular diseases – from molecular to clinical level | 10.46793/KARNEF25.013P | 13-18 |
Sebastjan Bevc, Tadej Petreski, Luka Varda, Nejc Piko, Robert Ekart, Radovan Hojs, Vitamin D and cardiorenal diseases | 10.46793/KARNEF25.019B | 19-26 |
Dejan Pilčević, Violeta Rabrenović, Milica Petrović, Neven Vavić, Nemanja Đenić, The role of uremic toxins on the development of cardiovascular damages | 10.46793/KARNEF25.027P | 27-35 |
Suzzane R. Hayman, Amyloidosis as a cause or factor in the progression of cardiorenal damage | 10.46793/KARNEF25.036H | 35-43 |
Isidre Vilacosta, Valvular heart disease in patients with chronic kidney disease – modern aspects of diagnosis and treatment | 10.46793/KARNEF25.045V | 44-47 |
Vesna D. Garovic, Uncontrolled hypertension in pregnancy | 10.46793/KARNEF25.049G | 48-52 |
Nikola Laban, Renovascular hypertension from the aspect of modern radiological diagnostics | 10.46793/KARNEF25.054L | 53-59 |
Vesna Stokanović, Vascular calcifications in cardiorenal diseases – the role of radiologist in diagnosis and prognosis | 10.46793/KARNEF25.062S | 60-66 |
Olga Nedeljkovic-Arsenovic, Magnetic resonance in the cardiovascular diseases – the great diagnostic challenge of 21st century | 10.46793/KARNEF25.069NA | 67-73 |
Alexandros Kallifatidis, Assessment of the state of perfusion of the cardiac and kidneys – the importance in early diagnosis and prevention | 10.46793/KARNEF25.076K | 74-81 |
Zorana Vasiljevic, Predrag Mitrovic, Dubravka Rajic, Natasa Zlatic, Coronary artery disease in patients with chronic kidney disease – is prevention possible? | 10.46793/KARNEF25.058V | 82-84 |
Pavel Skok, Is the repair of microbiotic imbalance the beginning of the story of cardiorenal protection? | 10.46793/KARNEF25.088S | 85-91 |
Zorica M. Dimitrijevic, Residual Kidney Function and Prevention of Cardiovascular Risk – Have We Said It All? | 10.46793/KARNEF25.095D | 92-102 |
Sonja Radenković, Diuretic therapy in heart and kidney diseases – where are we going wrong? | 10.46793/KARNEF25.107R | 103-118 |
Davide Viggiano, Effects of Pulmonary Hypertension in Patients with Chronic Kidney Disease | 10.46793/KARNEF25.124V | 119-121 |
Milan Radović, Current and future prospects in treatment of pulmonary hypertension? | 10.46793/KARNEF25.127R | 122-130 |
Robert Ekart, Nejc Piko, Luka Varda, Tadej Petreski, Sebastjan Bevc, Radovan Hojs, The role of sacubitril/valsartan in patients with advanced chronic kidney disease and heart failure | 10.46793/KARNEF25.136E | 131-136 |
Paolo Raggi, Luis D’Marco, Slowing progression of cardiovascular calcification with SNF472 in Hemodialysis Patients | Abstract | 137 |
Bernard Canaud, Mechanisms Supporting the Clinical Benefits of Hemodiafiltration: A Comprehensive Review | 10.46793/KARNEF25.144C | 138-158 |
Neven Vavić, Jelena Tadić, Katarina Obrenčević, Use of SGLT2i after kidney transplantation, first experiences | 10.46793/KARNEF25.165V | 159-162 |
Fulvio Floccari, Cardiorenal-anemia syndrome and iron deficiency: new challenges in prevention and treatment | 10.46793/KARNEF25.170F | 163-173 |
Jelena Nesović Ostojić, Sanjin Kovačević, Nikola Mitović, Aleksandra Nenadović, Andrija Vuković, Mirjana Jovanović, When, how, and why is it necessary to assess kidney function in cardiovascular patients? | 10.46793/KARNEF25.182NO | 174-181 |
Andrew J. Krentz, Cardio-Renal-Metabolic connection – Do we have possibilities for solving this problem? | 10.46793/KARNEF25.190K | 182-194 |
Radovan Hojs, Robert Ekart, Sebastjan Bevc, Nina Vodošek Hojs, Obesity and cardionephrology – guidance on the management | 10.46793/KARNEF25.204H | 195-200 |
Sebastjan Bevc, Robert Ekart, Radovan Hojs, The role of a multidisciplinary team in managing the cardio-renal-metabolic continuum | 10.46793/KARNEF25.210B | 201-205 |
Edoardo Gronda, Massimo Iacoviello, Arduino Arduini, Sodium glucose co-transporter inhibitors put cardiovascular medicine at a crossroads- Cardiorenal interaction and clinical implications | 10.46793/KARNEF25.215G | 206-221 |
Ivana Šarac, The basic principles of diet therapy in the treatment of patients with associated heart and kidney diseases | 10.46793/KARNEF25.231S | 222-239 |
Sanjin Kovačević, Nikola Mitovic, Predrag Brkić, Jelena Nesovic Ostojic, Hyperbaric oxygenation and Acute kidney injury – Data obtained from experimental studies | 10.46793/KARNEF25.253K | 243-247 |
Andrija Vuković et all., Effects of hyperbaric oxygenation in macro- and oligo-elements composition in kidney tissue | 10.46793/KARNEF25.258V | 248-249 |
Mirjana Jovanovic, Bojana Stevanovic, Vladislav Pajovic, Tatjana Tasic, Maja Lozic, Ljiljana Djukic, Marija Kosic, David Murphy, Nina Japundzic Zigon, Role of vasopressin in adaptation to pregnancy in chronic hypertension | 10.46793/KARNEF25.260J | 250-256 |
Nikola Mitovic, Masa Jovanovic, Dragan Ilic, Djordje Kovacevic, Milica Milosevic, Sanjin Kovacevic, Jelena Nesovic Ostojic, Marija S. Stankovic, The impact of cadmium on the development of morphological and functional cardiac disruption in zebrafish (Danio rerio) | 10.46793/KARNEF25.268M | 257-264 |
Aleksandra Nenadović, Sanjin Kovacevic, Tamara Popovic, Jasmina Debeljak Martacic, Slavica Rankovic, Jelena Nesovic Ostojic, The impact of a long-term high-fat diet on the phospholipid fatty acid composition in renal and white adipose tissue | Abstract | 265-266 |
Igor Balevski, Nino Vreča, Rok Arh, Tadej Petreski, Sebastjan Bevc, Impact Of Chronic Kidney Disease On Mortality Rate In Patients Who Underwent Percutaneous Coronary Intervention In Left Main Coronary Artery Disease | Abstract | 267-268 |
Tadej Petreski, The impact of the number of antihypertensive drugs on blood pressure control and laboratory parameters | Abstract | 269-270 |
Dragan Mitić, The Role of Imaging in the Diagnosis of an Expansive Tumor Lesion as a Potential Cause of Renovascular Hypertension | 10.46793/KARNEF25.282M | 271-274 |
Ivana Stanković, Sonja Radenković, Nikola Laban, The Role of Computed Tomography (CT) in the Diagnosis of Renovascular Hypertension in Early Vascular Aging | 10.46793/KARNEF25.286S | 275-277 |
Miloš Marković, Značaj MSCT pregleda u dijagnostici i praćenju renovaskularne hipertenzije kao posledice okluzije renalne arterije kod pacijenta sa trombofilijom | 10.46793/KARNEF25.290M | 278-280 |
Danijela Tasić, Zorica Dimitrijević, Venous congestion and the kidney in cardiorenal syndrome | 10.46793/KARNEF25.293T | 281-306 |
Marija Takić, Danijela Ristić-Medić, Ivana Šarac, Effects of dietary intake of alpha-linolenic acid on parameters associated with cardiovascular risk in patients chronic kidney diseases | Abstract | 285 |
Goran Koraćević, Slađana Mićić, Milovan Stojanović, Uncontrolled arterial hypertension in the mirror of ethiopathogenetic, diagnostic and clinical aspects of the disease | 10.46793/KARNEF25.301K | 289-306 |
Davide Viggiano, Why are we talking about Na homeostasis in resistant hypertension again? | Abstract | 307-308 |
Tijana Azaševac, Arterijska hipertenzija i hronična bolesta bubrega – da li je sve pod kontrolom? | 10.46793/KARNEF25.321A | 309-315 |
Rodolfo Fernando Rivera, Novelties in Medicinal Therapy of Uncontrolled Arterial Hypertension: SGLT2 Inhibitors and What Else? | 10.46793/KARNEF25.328R | 316-319 |
Vladimir Miloradović, Neda Ćićarić, Approaches in the Treatment of Uncontrolled Hypertension | 10.46793/KARNEF25.332M | 320-323 |
Miroslav Radenkovic, Pharmacogenomics and uncontrolled arterial hypertension | 10.46793/KARNEF25.336R | 324-328 |
